To summarize, both established GLA-null hESC clones exhibited normal stem cell properties, and therefore, were suitable for differentiation into FD-specific cardiomyocytes to investigate the mechanisms of involvement of GLA deficiency in the pathology of FD cardiomyopathy. This evidence concerns the gene GLA and cardiomyopathy.